RecruitingNot applicableNCT06867471
Effects of Exogenous Ketosis on Proteinuria and Renal Function
Studying Nephrotic syndrome without extrarenal manifestations
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gødstrup Hospital
- Principal Investigator
- Trine Z Lyksholm, MDUniversity Clinic in Nephrology and Hypertenion, Godstrup Region Hospital
- Intervention
- Ketone Diol, R-1,3-butanediol (Ketone-IQ)(dietary_supplement)
- Enrollment
- 43 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2025
Study locations (1)
- University Clinic in Nephrology and Hypertension, Gødstrup Region Hospital, Herning, Jutland, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06867471 on ClinicalTrials.govOther trials for Nephrotic syndrome without extrarenal manifestations
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07267026A Study to Evaluate the Safety, Tolerability and PK of SK-09Consun Pharmaceutical Group
- RECRUITINGPHASE4NCT07219121Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental GlomerulosclerosisTravere Therapeutics, Inc.
- RECRUITINGPHASE3NCT05716880Ketoanalogues for Muscle Mass Loss in Nephrotic SyndromeMilitary Institute od Medicine National Research Institute
- RECRUITINGPHASE2NCT05003986Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesTravere Therapeutics, Inc.
- RECRUITINGNCT01209000Nephrotic Syndrome Study NetworkUniversity of Michigan
- RECRUITINGNCT01094327Proteinuria in Pre and Post TransplantUniversity of Miami
See all trials for Nephrotic syndrome without extrarenal manifestations →